Chronic neutrophilic leukemia laboratory findings: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Removing from Primary care)
 
(9 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Chronic neutrophilic leukemia}}
{{Chronic neutrophilic leukemia}}


{{CMG}}; {{AE}}{{Homa}}
{{CMG}}; {{AE}} {{Homa}}; {{GRR}} {{Nat}}


==Overview==
==Overview==
[[Laboratory]] findings consistent with the diagnosis of chronic neutrophilic leukemia (CNL) include [[chronic]] [[neutrophilia]]. Mild [[anemia]], [[thrombocytopenia]], elevation of [[lactate dehydrogenase]] and [[vitamin B12]].
A chronic elevated [[concentration]] of [[blood]] mature [[Neutrophil|neutrophils]] is [[diagnostic]] for chronic neutrophilic leukemia (CNL). There are other [[blood]], [[bone marrow]] and [[genetic]] [[test]]<nowiki/>s which help the [[diagnosis]] of CNL.
 


==Laboratory Findings==
==Laboratory Findings==


A chronic elevated concentration of blood mature [[Neutrophil|neutrophils]] is diagnostic for CNL.<ref name="ElliottHanson2004">{{cite journal|last1=Elliott|first1=M A|last2=Hanson|first2=C A|last3=Dewald|first3=G W|last4=Smoley|first4=S A|last5=Lasho|first5=T L|last6=Tefferi|first6=A|title=WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature|journal=Leukemia|volume=19|issue=2|year=2004|pages=313–317|issn=0887-6924|doi=10.1038/sj.leu.2403562}}</ref>
A chronic elevated [[concentration]] of [[blood]] mature [[Neutrophil|neutrophils]] is [[diagnostic]] for CNL.<ref name="ElliottHanson2004">{{cite journal|last1=Elliott|first1=M A|last2=Hanson|first2=C A|last3=Dewald|first3=G W|last4=Smoley|first4=S A|last5=Lasho|first5=T L|last6=Tefferi|first6=A|title=WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature|journal=Leukemia|volume=19|issue=2|year=2004|pages=313–317|issn=0887-6924|doi=10.1038/sj.leu.2403562}}</ref>
 
Some patients with CNL may have:<ref name="HasleOlesen1996">{{cite journal|last1=Hasle|first1=Henrik|last2=Olesen|first2=Gitte|last3=Kerndrup|first3=GITTE|last4=Philip|first4=Preben|last5=Jacobsen|first5=Niels|title=Chronic neutrophil leukaemia in adolescence and young adulthood|journal=British Journal of Haematology|volume=94|issue=4|year=1996|pages=628–630|issn=0007-1048|doi=10.1046/j.1365-2141.1996.7082329.x}}</ref><ref name="ElliottHanson2004">{{cite journal|last1=Elliott|first1=M A|last2=Hanson|first2=C A|last3=Dewald|first3=G W|last4=Smoley|first4=S A|last5=Lasho|first5=T L|last6=Tefferi|first6=A|title=WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature|journal=Leukemia|volume=19|issue=2|year=2004|pages=313–317|issn=0887-6924|doi=10.1038/sj.leu.2403562}}</ref><ref name="Elliott2006">{{cite journal|last1=Elliott|first1=Michelle A.|title=Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined|journal=Best Practice & Research Clinical Haematology|volume=19|issue=3|year=2006|pages=571–593|issn=15216926|doi=10.1016/j.beha.2005.07.012}}</ref>
*


Some [[patients]] with CNL may have:<ref name="ElliottHanson2004">{{cite journal|last1=Elliott|first1=M A|last2=Hanson|first2=C A|last3=Dewald|first3=G W|last4=Smoley|first4=S A|last5=Lasho|first5=T L|last6=Tefferi|first6=A|title=WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature|journal=Leukemia|volume=19|issue=2|year=2004|pages=313–317|issn=0887-6924|doi=10.1038/sj.leu.2403562}}</ref><ref name="HasleOlesen1996">{{cite journal|last1=Hasle|first1=Henrik|last2=Olesen|first2=Gitte|last3=Kerndrup|first3=GITTE|last4=Philip|first4=Preben|last5=Jacobsen|first5=Niels|title=Chronic neutrophil leukaemia in adolescence and young adulthood|journal=British Journal of Haematology|volume=94|issue=4|year=1996|pages=628–630|issn=0007-1048|doi=10.1046/j.1365-2141.1996.7082329.x}}</ref><ref name="Elliott2006">{{cite journal|last1=Elliott|first1=Michelle A.|title=Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined|journal=Best Practice & Research Clinical Haematology|volume=19|issue=3|year=2006|pages=571–593|issn=15216926|doi=10.1016/j.beha.2005.07.012}}</ref><ref name="ArberOrazi2016">{{cite journal|last1=Arber|first1=D. A.|last2=Orazi|first2=A.|last3=Hasserjian|first3=R.|last4=Thiele|first4=J.|last5=Borowitz|first5=M. J.|last6=Le Beau|first6=M. M.|last7=Bloomfield|first7=C. D.|last8=Cazzola|first8=M.|last9=Vardiman|first9=J. W.|title=The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia|journal=Blood|volume=127|issue=20|year=2016|pages=2391–2405|issn=0006-4971|doi=10.1182/blood-2016-03-643544}}</ref><ref name="ElliottPardanani2015">{{cite journal|last1=Elliott|first1=Michelle A.|last2=Pardanani|first2=Animesh|last3=Hanson|first3=Curtis A.|last4=Lasho|first4=Terra L.|last5=Finke|first5=Christy M.|last6=Belachew|first6=Alem A.|last7=Tefferi|first7=Ayalew|title=ASXL1mutations are frequent and prognostically detrimental inCSF3R-mutated chronic neutrophilic leukemia|journal=American Journal of Hematology|volume=90|issue=7|year=2015|pages=653–656|issn=03618609|doi=10.1002/ajh.24031}}</ref><ref>{{Cite journal
| author = [[John T. Reilly]]
| title = Chronic neutrophilic leukaemia: a distinct clinical entity?
| journal = [[British journal of haematology]]
| volume = 116
| issue = 1
| pages = 10–18
| year = 2002
| month = January
| pmid = 11841395
}}</ref><ref name="PiliotisKutas2009">{{cite journal|last1=Piliotis|first1=E.|last2=Kutas|first2=G.|last3=Lipton|first3=J.H.|title=Allogeneic Bone Marrow Transplantation in the Management of Chronic Neutrophilic Leukemia|journal=Leukemia & Lymphoma|volume=43|issue=10|year=2009|pages=2051–2054|issn=1042-8194|doi=10.1080/1042819021000016087}}</ref><ref name="DonatoCroci1986">{{cite journal|last1=Donato|first1=Carlo Di|last2=Croci|first2=Gianfranco|last3=Lazzari|first3=Stefano|last4=Scarduelli|first4=Laura|last5=Vignoli|first5=Roberto|last6=Buia|first6=Marco|last7=Tramaloni|first7=Casimiro|last8=Maccari|first8=Sergio|last9=Plancher|first9=Angelo Cesare|title=Chronic Neutrophilic Leukemia: Description of a New Case with Karyotypic Abnormalities|journal=American Journal of Clinical Pathology|volume=85|issue=3|year=1986|pages=369–371|issn=1943-7722|doi=10.1093/ajcp/85.3.369}}</ref><ref>{{Cite journal
| author = [[Michelle A. Elliott]]
| title = Chronic neutrophilic leukemia: a contemporary review
| journal = [[Current hematology reports]]
| volume = 3
| issue = 3
| pages = 210–217
| year = 2004
| month = May
| pmid = 15087070
}}</ref><ref>{{Cite journal
| author = [[Donald P. Mc Lornan]], [[Melanie J. Percy]], [[Amy V. Jones]], [[Nicholas C. P. Cross]] & [[Mary Frances Mc Mullin]]
| title = Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation
| journal = [[Haematologica]]
| volume = 90
| issue = 12
| pages = 1696–1697
| year = 2005
| month = December
| pmid = 16330446
}}</ref><ref name="PardananiLasho2013">{{cite journal|last1=Pardanani|first1=A|last2=Lasho|first2=T L|last3=Laborde|first3=R R|last4=Elliott|first4=M|last5=Hanson|first5=C A|last6=Knudson|first6=R A|last7=Ketterling|first7=R P|last8=Maxson|first8=J E|last9=Tyner|first9=J W|last10=Tefferi|first10=A|title=CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia|journal=Leukemia|volume=27|issue=9|year=2013|pages=1870–1873|issn=0887-6924|doi=10.1038/leu.2013.122}}</ref><ref name="MaxsonGotlib2013">{{cite journal|last1=Maxson|first1=Julia E.|last2=Gotlib|first2=Jason|last3=Pollyea|first3=Daniel A.|last4=Fleischman|first4=Angela G.|last5=Agarwal|first5=Anupriya|last6=Eide|first6=Christopher A.|last7=Bottomly|first7=Daniel|last8=Wilmot|first8=Beth|last9=McWeeney|first9=Shannon K.|last10=Tognon|first10=Cristina E.|last11=Pond|first11=J. Blake|last12=Collins|first12=Robert H.|last13=Goueli|first13=Basem|last14=Oh|first14=Stephen T.|last15=Deininger|first15=Michael W.|last16=Chang|first16=Bill H.|last17=Loriaux|first17=Marc M.|last18=Druker|first18=Brian J.|last19=Tyner|first19=Jeffrey W.|title=Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML|journal=New England Journal of Medicine|volume=368|issue=19|year=2013|pages=1781–1790|issn=0028-4793|doi=10.1056/NEJMoa1214514}}</ref><ref name="GotlibMaxson2013">{{cite journal|last1=Gotlib|first1=J.|last2=Maxson|first2=J. E.|last3=George|first3=T. I.|last4=Tyner|first4=J. W.|title=The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment|journal=Blood|volume=122|issue=10|year=2013|pages=1707–1711|issn=0006-4971|doi=10.1182/blood-2013-05-500959}}</ref><ref name="MeggendorferHaferlach2014">{{cite journal|last1=Meggendorfer|first1=M.|last2=Haferlach|first2=T.|last3=Alpermann|first3=T.|last4=Jeromin|first4=S.|last5=Haferlach|first5=C.|last6=Kern|first6=W.|last7=Schnittger|first7=S.|title=Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia|journal=Haematologica|volume=99|issue=12|year=2014|pages=e244–e246|issn=0390-6078|doi=10.3324/haematol.2014.113159}}</ref><ref name="CuiLi2014">{{cite journal|last1=Cui|first1=Yajuan|last2=Li|first2=Bing|last3=Gale|first3=Robert Peter|last4=Jiang|first4=Qian|last5=Xu|first5=Zefeng|last6=Qin|first6=Tiejun|last7=Zhang|first7=Peihong|last8=Zhang|first8=Yue|last9=Xiao|first9=Zhijian|title=CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia|journal=Journal of Hematology & Oncology|volume=7|issue=1|year=2014|issn=1756-8722|doi=10.1186/s13045-014-0077-1}}</ref><ref name="DaoTyner2015">{{cite journal|last1=Dao|first1=K.-H. T.|last2=Tyner|first2=J. W.|title=What's different about atypical CML and chronic neutrophilic leukemia?|journal=Hematology|volume=2015|issue=1|year=2015|pages=264–271|issn=1520-4391|doi=10.1182/asheducation-2015.1.264}}</ref>
===== '''Blood tests:''' =====
===== '''Blood tests:''' =====
* [[Peripheral blood]] [[White blood cells]] (WBC) ≥25 ×10<sup>9</sup>/L
* [[Peripheral blood]] [[White blood cells]] (WBC) ≥25 ×10<sup>9</sup>/L
Line 21: Line 50:
* Mild [[anemia]]
* Mild [[anemia]]
* [[Thrombocytopenia]]
* [[Thrombocytopenia]]
===== Bone marrow test: =====
*
*Hypercellularity of [[bone marrow]].
*[[Neutrophil granulocytes]] increased in percentage and number
*Normal [[neutrophil]] [[maturation]]
*[[Myeloblast|Myeloblasts]] <5% of [[nucleated]] cells
*Presence of translocation between chromosomes 9 and 22.
*Presence of BCR-ABL transcripts by RT-PCR.


==== Blood chemistry tests: ====
==== Blood chemistry tests: ====
Line 35: Line 55:


==== Blood vitamin analysis: ====
==== Blood vitamin analysis: ====
*Evation of [[vitamin B12]]  
*Elevation of [[vitamin B12]]  
 
==== Conventional cytogenetics and karyotyping: ====
* This test looks at chromosomes under a microscope.
* The chromosomes can best be seen when the cell is dividing, so a sample of [[blood]] or [[bone marrow]] must be grown ''in vitro'' so that the cells start to divide.
* The leukemia cells in all [[CML]] patients contain an abnormal [[chromosome]] called the [[Philadelphia (Ph) chromosome]], which looks like a shortened version of chromosome 22.
 
==== Fluorescent in situ hybridization (FISH): ====
* FISH is another way to look at chromosomes and is more precise than conventional cytogenetics because it uses fluorescent dyes that only attach to specific genes or parts of [[chromosomes]].
* In [[CML]], FISH can be used to look for specific pieces of the BCR-ABL [[gene]] on chromosomes.
 
==== Polymerase chain reaction (PCR): ====
* This is a highly sensitive test that can be used to look for the BCR-ABL product in [[leukemia]] cells. PCR is useful for quantitation.
* It can be done on blood or bone marrow samples and can detect very small amounts of BCR-ABL, even when Philadelphia chromosome can not be detected with cytogenetic testing.
* It can be used after treatment to see if copies of the BCR-ABL gene are still present.
* If copies of this gene are found it means that the [[leukemia]] is still present.


==== Genetic tests: ====
* Mutations which may seen:
** [[CSF3R]]
** [[SETBP1]]
** [[ASXL1]]
** TET2
** [[EZH2]]
** KDM6A


* [[Cytogenetic]] abnormalities which may seen:
**[[Trisomy 8]]
**[[Trisomy 21]]
**Deletion 11q
**Deletion 20q6
**Deletion Y
**Trisomy 7
**[[Trisomy 9]]
**Detection of JAK2V617F
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 58: Line 80:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Medicine]]
[[Category:Medicine]]
Line 63: Line 86:
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Immunology]]
[[Category:Immunology]]
[[Category:Primary care]]

Latest revision as of 20:57, 29 July 2020

Chronic neutrophilic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Chronic neutrophilic leukemia from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic neutrophilic leukemia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic neutrophilic leukemia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic neutrophilic leukemia laboratory findings

CDC on Chronic neutrophilic leukemia laboratory findings

Chronic neutrophilic leukemia laboratory findings in the news

Blogs on Chronic neutrophilic leukemia laboratory findings

Directions to Hospitals Treating Chronic neutrophilic leukemia

Risk calculators and risk factors for Chronic neutrophilic leukemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

A chronic elevated concentration of blood mature neutrophils is diagnostic for chronic neutrophilic leukemia (CNL). There are other blood, bone marrow and genetic tests which help the diagnosis of CNL.


Laboratory Findings

A chronic elevated concentration of blood mature neutrophils is diagnostic for CNL.[1]

Some patients with CNL may have:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]

Blood tests:

Blood chemistry tests:

Blood vitamin analysis:

Genetic tests:

References

  1. ↑ 1.0 1.1 Elliott, M A; Hanson, C A; Dewald, G W; Smoley, S A; Lasho, T L; Tefferi, A (2004). "WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature". Leukemia. 19 (2): 313–317. doi:10.1038/sj.leu.2403562. ISSN 0887-6924.
  2. ↑ Hasle, Henrik; Olesen, Gitte; Kerndrup, GITTE; Philip, Preben; Jacobsen, Niels (1996). "Chronic neutrophil leukaemia in adolescence and young adulthood". British Journal of Haematology. 94 (4): 628–630. doi:10.1046/j.1365-2141.1996.7082329.x. ISSN 0007-1048.
  3. ↑ Elliott, Michelle A. (2006). "Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined". Best Practice & Research Clinical Haematology. 19 (3): 571–593. doi:10.1016/j.beha.2005.07.012. ISSN 1521-6926.
  4. ↑ Arber, D. A.; Orazi, A.; Hasserjian, R.; Thiele, J.; Borowitz, M. J.; Le Beau, M. M.; Bloomfield, C. D.; Cazzola, M.; Vardiman, J. W. (2016). "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia". Blood. 127 (20): 2391–2405. doi:10.1182/blood-2016-03-643544. ISSN 0006-4971.
  5. ↑ Elliott, Michelle A.; Pardanani, Animesh; Hanson, Curtis A.; Lasho, Terra L.; Finke, Christy M.; Belachew, Alem A.; Tefferi, Ayalew (2015). "ASXL1mutations are frequent and prognostically detrimental inCSF3R-mutated chronic neutrophilic leukemia". American Journal of Hematology. 90 (7): 653–656. doi:10.1002/ajh.24031. ISSN 0361-8609.
  6. ↑ John T. Reilly (2002). "Chronic neutrophilic leukaemia: a distinct clinical entity?". British journal of haematology. 116 (1): 10–18. PMID 11841395. Unknown parameter |month= ignored (help)
  7. ↑ Piliotis, E.; Kutas, G.; Lipton, J.H. (2009). "Allogeneic Bone Marrow Transplantation in the Management of Chronic Neutrophilic Leukemia". Leukemia & Lymphoma. 43 (10): 2051–2054. doi:10.1080/1042819021000016087. ISSN 1042-8194.
  8. ↑ Donato, Carlo Di; Croci, Gianfranco; Lazzari, Stefano; Scarduelli, Laura; Vignoli, Roberto; Buia, Marco; Tramaloni, Casimiro; Maccari, Sergio; Plancher, Angelo Cesare (1986). "Chronic Neutrophilic Leukemia: Description of a New Case with Karyotypic Abnormalities". American Journal of Clinical Pathology. 85 (3): 369–371. doi:10.1093/ajcp/85.3.369. ISSN 1943-7722.
  9. ↑ Michelle A. Elliott (2004). "Chronic neutrophilic leukemia: a contemporary review". Current hematology reports. 3 (3): 210–217. PMID 15087070. Unknown parameter |month= ignored (help)
  10. ↑ Donald P. Mc Lornan, Melanie J. Percy, Amy V. Jones, Nicholas C. P. Cross & Mary Frances Mc Mullin (2005). "Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation". Haematologica. 90 (12): 1696–1697. PMID 16330446. Unknown parameter |month= ignored (help)
  11. ↑ Pardanani, A; Lasho, T L; Laborde, R R; Elliott, M; Hanson, C A; Knudson, R A; Ketterling, R P; Maxson, J E; Tyner, J W; Tefferi, A (2013). "CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia". Leukemia. 27 (9): 1870–1873. doi:10.1038/leu.2013.122. ISSN 0887-6924.
  12. ↑ Maxson, Julia E.; Gotlib, Jason; Pollyea, Daniel A.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.; Tognon, Cristina E.; Pond, J. Blake; Collins, Robert H.; Goueli, Basem; Oh, Stephen T.; Deininger, Michael W.; Chang, Bill H.; Loriaux, Marc M.; Druker, Brian J.; Tyner, Jeffrey W. (2013). "Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML". New England Journal of Medicine. 368 (19): 1781–1790. doi:10.1056/NEJMoa1214514. ISSN 0028-4793.
  13. ↑ Gotlib, J.; Maxson, J. E.; George, T. I.; Tyner, J. W. (2013). "The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment". Blood. 122 (10): 1707–1711. doi:10.1182/blood-2013-05-500959. ISSN 0006-4971.
  14. ↑ Meggendorfer, M.; Haferlach, T.; Alpermann, T.; Jeromin, S.; Haferlach, C.; Kern, W.; Schnittger, S. (2014). "Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia". Haematologica. 99 (12): e244–e246. doi:10.3324/haematol.2014.113159. ISSN 0390-6078.
  15. ↑ Cui, Yajuan; Li, Bing; Gale, Robert Peter; Jiang, Qian; Xu, Zefeng; Qin, Tiejun; Zhang, Peihong; Zhang, Yue; Xiao, Zhijian (2014). "CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia". Journal of Hematology & Oncology. 7 (1). doi:10.1186/s13045-014-0077-1. ISSN 1756-8722.
  16. ↑ Dao, K.-H. T.; Tyner, J. W. (2015). "What's different about atypical CML and chronic neutrophilic leukemia?". Hematology. 2015 (1): 264–271. doi:10.1182/asheducation-2015.1.264. ISSN 1520-4391.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Chronic_neutrophilic_leukemia_laboratory_findings&oldid=1636103"